{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:19:09Z","timestamp":1768713549904,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.jhep.2004.11.025","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T21:44:13Z","timestamp":1103147053000},"page":"315-322","source":"Crossref","is-referenced-by-count":190,"title":["Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"42","author":[{"given":"Nizar N.","family":"Zein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"for the Etanercept Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2004.11.025_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1007259","article-title":"Epidemiology of hepatitis C in the West","volume":"15","author":"Alter","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2004.11.025_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib3","first-page":"390A","article-title":"Projecting the future healthcare burden from hepatitis C in the United States (abstract)","volume":"28","author":"Davis","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.11.025_bib4","first-page":"229","article-title":"Interferons in the management of viral hepatitis","volume":"4","author":"Zein","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1016\/j.jhep.2004.11.025_bib5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2004.11.025_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.179.3.841","article-title":"Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis","volume":"179","author":"Gonzalez-Amaro","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2004.11.025_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0168-8278(95)80108-1","article-title":"Iron storage, lipid peroxidation and glutathion turnover in chronic anti-HCV positive hepatitis","volume":"22","author":"Farinati","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.11.025_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0891-5849(96)00044-5","article-title":"Association between reactive oxygen species and disease activity in chronic hepatitis C","volume":"21","author":"De Maria","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0891-5849(97)00437-1","article-title":"Superoxide dismutase in patients with chronic hepatitis C virus infection","volume":"24","author":"Larrea","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0676.1996.tb00768.x","article-title":"Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C","volume":"16","author":"Fukuda","year":"1996","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2004.11.025_bib15","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C","volume":"23","author":"Larrea","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.11.025_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib17","first-page":"228A","article-title":"Phase III trial of DMARD failing rheumatoid arthritis patients with TNF receptor p75 Fc fusion protein (TNFR:Fc, ENBREL\u2122) (abstract)","volume":"46","author":"Moreland","year":"1998","journal-title":"J Invest Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib19","first-page":"249A","article-title":"Recombinant human dimeric tumor necrosis factor (TNF) receptor (TNFR:Fc): safety and pharmacokinetics in human volunteers (abstract)","volume":"41","author":"Nam","year":"1993","journal-title":"Clin Res"},{"key":"10.1016\/j.jhep.2004.11.025_bib20","first-page":"229A","article-title":"Longterm treatment of DMARD failing rheumatoid arthritis patients with TNF receptor p75 Fc fusion protein (TNFR:Fc; ENBRE\u2122) (abstract)","volume":"46","author":"Moreland","year":"1998","journal-title":"J Invest Med"},{"key":"10.1016\/j.jhep.2004.11.025_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2004.11.025_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.11.025_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","article-title":"The biology of cachectin\/TNF\u2014a primary mediator of the host response","volume":"7","author":"Beutler","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhep.2004.11.025_bib24","first-page":"169","article-title":"Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy","volume":"4","author":"Olsson","year":"1993","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jhep.2004.11.025_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF02093821","article-title":"IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C","volume":"41","author":"Kishihara","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2004.11.025_bib26","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1023\/A:1018804426724","article-title":"Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection","volume":"42","author":"Nelson","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2004.11.025_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2249.1998.00469.x","article-title":"Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection","volume":"111","author":"Kallinowski","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2004.11.025_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex: reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2004.11.025_bib29","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K","article-title":"Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis","volume":"42","author":"Maurice","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2004.11.025_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors","volume":"60","author":"Berg","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jhep.2004.11.025_bib31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/gast.2002.36045","article-title":"Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C","volume":"123","author":"Kamal","year":"2002","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827804005446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827804005446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T09:22:59Z","timestamp":1548926579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827804005446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0168827804005446"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2004.11.025","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}